Cargando…
Correction: A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221638/ https://www.ncbi.nlm.nih.gov/pubmed/32348282 http://dx.doi.org/10.2196/18411 |
_version_ | 1783533406764662784 |
---|---|
author | Huang, Zhilian Tan, Eberta Lum, Elaine Sloot, Peter Boehm, Bernhard Otto Car, Josip |
author_facet | Huang, Zhilian Tan, Eberta Lum, Elaine Sloot, Peter Boehm, Bernhard Otto Car, Josip |
author_sort | Huang, Zhilian |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7221638 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | JMIR Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-72216382020-05-18 Correction: A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial Huang, Zhilian Tan, Eberta Lum, Elaine Sloot, Peter Boehm, Bernhard Otto Car, Josip JMIR Mhealth Uhealth Corrigenda and Addenda JMIR Publications 2020-04-29 /pmc/articles/PMC7221638/ /pubmed/32348282 http://dx.doi.org/10.2196/18411 Text en ©Zhilian Huang, Eberta Tan, Elaine Lum, Peter Sloot, Bernhard Otto Boehm, Josip Car. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 29.04.2020. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR mHealth and uHealth, is properly cited. The complete bibliographic information, a link to the original publication on http://mhealth.jmir.org/, as well as this copyright and license information must be included. |
spellingShingle | Corrigenda and Addenda Huang, Zhilian Tan, Eberta Lum, Elaine Sloot, Peter Boehm, Bernhard Otto Car, Josip Correction: A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial |
title | Correction: A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial |
title_full | Correction: A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial |
title_fullStr | Correction: A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial |
title_full_unstemmed | Correction: A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial |
title_short | Correction: A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial |
title_sort | correction: a smartphone app to improve medication adherence in patients with type 2 diabetes in asia: feasibility randomized controlled trial |
topic | Corrigenda and Addenda |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221638/ https://www.ncbi.nlm.nih.gov/pubmed/32348282 http://dx.doi.org/10.2196/18411 |
work_keys_str_mv | AT huangzhilian correctionasmartphoneapptoimprovemedicationadherenceinpatientswithtype2diabetesinasiafeasibilityrandomizedcontrolledtrial AT taneberta correctionasmartphoneapptoimprovemedicationadherenceinpatientswithtype2diabetesinasiafeasibilityrandomizedcontrolledtrial AT lumelaine correctionasmartphoneapptoimprovemedicationadherenceinpatientswithtype2diabetesinasiafeasibilityrandomizedcontrolledtrial AT slootpeter correctionasmartphoneapptoimprovemedicationadherenceinpatientswithtype2diabetesinasiafeasibilityrandomizedcontrolledtrial AT boehmbernhardotto correctionasmartphoneapptoimprovemedicationadherenceinpatientswithtype2diabetesinasiafeasibilityrandomizedcontrolledtrial AT carjosip correctionasmartphoneapptoimprovemedicationadherenceinpatientswithtype2diabetesinasiafeasibilityrandomizedcontrolledtrial |